三氮唑嘧啶酮结构式
|
常用名 | 三氮唑嘧啶酮 | 英文名 | 2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5-one |
|---|---|---|---|---|
| CAS号 | 27277-00-5 | 分子量 | 207.23200 | |
| 密度 | 1.44g/cm3 | 沸点 | 459.9ºC at 760 mmHg | |
| 分子式 | C9H13N5O | 熔点 | 161.8-163ºC | |
| MSDS | 美版 | 闪点 | 231.9ºC |
| 中文名 | 2-氨基-6-甲基-4-丙基-[1,2,4]三唑并[1,5-a]嘧啶-5-酮 |
|---|---|
| 英文名 | 2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5-one |
| 中文别名 | 2-氨基-6-甲基-4-丙基-4H[1,2,4]三唑-[1.5-A]嘧啶-5-酮 | 三氮唑嘧啶酮 |
| 英文别名 | 更多 |
| 密度 | 1.44g/cm3 |
|---|---|
| 沸点 | 459.9ºC at 760 mmHg |
| 熔点 | 161.8-163ºC |
| 分子式 | C9H13N5O |
| 分子量 | 207.23200 |
| 闪点 | 231.9ºC |
| 精确质量 | 207.11200 |
| PSA | 78.21000 |
| LogP | 0.77280 |
| 外观性状 | 白色固体 |
| 蒸汽压 | 1.22E-08mmHg at 25°C |
| 折射率 | 1.696 |
| 储存条件 | Store at +4°C |
| 水溶解性 | DMSO: 13 mg/mL |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | UN 2811 |
| WGK德国 | 1 |
| 包装等级 | III |
| 危险类别 | 6.1(b) |
| 海关编码 | 2933990090 |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
Psychopharmacology 77(4) , 309-16, (1982) The significance of a characteristic symptomatology (hypothermia, hypoactivity, forepaw shaking, grooming, head twitches) as a potential in vivo correlate of enhanced availability of brain adenosine c... |
|
|
Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.
Neuropharmacology 25(10) , 1119-26, (1986) The antidepressant potential of rolipram and inhibitors of phosphodiesterase (PDE) which are selective for cyclic AMP has previously been ascribed to enhancement of central noradrenergic transmission ... |
|
|
Effects of isoprenaline, levodopa and a phosphodiesterase inhibitor (ICI 63,197) on cyclic AMP levels and contractions of soleus muscles in anesthetized cats.
Clin. Exp. Pharmacol. Physiol. 8(1) , 57-66, (1981) 1. Cyclic AMP levels have been determined in the soleus muscles of anaesthetized cats in the absence of drugs, and during depression of incomplete tetanic contractions produced by (-)-isoprenaline, IC... |
| 2-Amino-6-methyl-4-propyl-1,2,4-triazolo[1,5-a]pyrimidin-5(4H)-on |
| 2-AMIO-6-METHYL-4-PROPYL-4H-[1,2,4] TRIAZOLO[1,5-A]PYRIMIDIN-5-ONE |
| 1,2,4Triazolo1,5-apyrimidin-5(4H)-one,2-amino-6-methyl-4-propyl |
| PP-796 emetic |
| 2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one |
| 2-AMINO-6-METHYL-4-PROPYL-4H-[1,2,4]TRIAZOLO-[1,5-A]PYRIMIDIN-5-ONE |
| EINECS 248-383-5 |
| MFCD06407961 |
| AMINOPROPYLTRIAZOLOPYRIMIDONE |
| 2-azanyl-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5-one |
| 2-amino-6-methyl-5-oxo-4-n-propyl-4,5-dihydro-s-triazolo [1,5-a] pyrimidine |
查看所有供应商和价格请点击：